Drug discovery: Priming the antimalarial pipeline.
Fidock
David A
DA
D000818:Animals; D000962:Antimalarials / Q000032:analysis* / Q000302:isolation & purification / Q000494:pharmacology*; D037621:Artemisinins / Q000494:pharmacology / Q000627:therapeutic use; D055808:Drug Discovery; D004351:Drug Resistance / Q000187:drug effects; D004912:Erythrocytes / Q000187:drug effects / Q000469:parasitology; D006801:Humans; D016778:Malaria, Falciparum / Q000188:drug therapy / Q000469:parasitology; D051379:Mice; D010802:Phylogeny; D010963:Plasmodium falciparum / Q000187:drug effects* / Q000235:genetics / Q000254:growth & development / Q000378:metabolism; D054852:Small Molecule Libraries / Q000032:analysis / Q000737:chemistry / Q000494:pharmacology
D000962:Antimalarials; D037621:Artemisinins; D054852:Small Molecule Libraries